The DOI matches its Crossref record.
The Etiology of Community‐Acquired Pneumonia in Australia: Why Penicillin plus Doxycycline or a Macrolide Is the Most Appropriate Therapy
Abstract
BACKGROUND: Available data on the etiology of community-acquired pneumonia (CAP) in Australia are very limited. Local treatment guidelines promote the use of combination therapy with agents such as penicillin or amoxycillin combined with either doxycycline or a macrolide. METHODS: The Australian CAP Study (ACAPS) was a prospective, multicenter study of 885 episodes of CAP in which all patients underwent detailed assessment for bacterial and viral pathogens (cultures, urinary antigen testing, serological methods, and polymerase chain reaction). Antibiotic agents and relevant clinical outcomes were recorded. RESULTS: The etiology was identified in 404 (45.6%) of 885 episodes, with the most frequent causes being Streptococcus pneumoniae (14%), Mycoplasma pneumoniae (9%), and respiratory viruses (15%; influenza, picornavirus, respiratory syncytial virus, parainfluenza virus, and adenovirus). Antibiotic-resistant pathogens were rare: only 5.4% of patients had an infection for which therapy with penicillin plus doxycycline would potentially fail. Concordance with local antibiotic recommendations was high (82.4%), with the most commonly prescribed regimens being a penicillin plus either doxycycline or a macrolide (55.8%) or ceftriaxone plus either doxycycline or a macrolide (36.8%). The 30-day mortality rate was 5.6% (50 of 885 episodes), and mechanical ventilation or vasopressor support were required in 94 episodes (10.6%). Outcomes were not compromised by receipt of narrower-spectrum beta-lactams, and they did not differ on the basis of whether a pathogen was identified. CONCLUSIONS: The vast majority of patients with CAP can be treated successfully with narrow-spectrum beta-lactam treatment, such as penicillin combined with doxycycline or a macrolide. Greater use of such therapy could potentially reduce the emergence of antibiotic resistance among common bacterial pathogens.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Tong, S. Y. C., Davis, J. S., Eichenberger, E., Holland, T. L., & Fowler, V. G. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00134-14 · Cited by 5,192
Community-Acquired Pneumonia Requiring Hospitalization among U.S. Adults
Jain, S., Self, W. H., Wunderink, R. G., Fakhran, S., Balk, R., Bramley, A. M., Reed, C., Grijalva, C. G., Anderson, E. J., Courtney, D. M., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1500245 · Cited by 2,323
Self-citationRuuskanen, O., Lahti, E., Jennings, L. C., & Murdoch, D. R. (2011) · The Lancet · doi:10.1016/s0140-6736(10)61459-6 · Cited by 1,124
Guidelines for the management of adult lower respiratory tract infections - Full version
Woodhead, M., Blasi, F., Ewig, S., Garau, J., Huchon, G., Ieven, M., Ortqvist, A., Schaberg, T., Torres, A., van der Heijden, G., et al. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03672.x · Cited by 942
Charles, P. G. P., Wolfe, R., Whitby, M., Fine, M. J., Fuller, A. J., Stirling, R., Wright, A. A., Ramirez, J. A., Christiansen, K. J., Waterer, G. W., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/589754 · Cited by 536
Self-citationComprehensive Molecular Testing for Respiratory Pathogens in Community-Acquired Pneumonia
Gadsby, N. J., Russell, C. D., McHugh, M. P., Mark, H., Conway Morris, A., Laurenson, I. F., Hill, A. T., & Templeton, K. E. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/civ1214 · Cited by 446
Said, M. A., Johnson, H. L., Nonyane, B. A. S., Deloria-Knoll, M., O′Brien, K. L., & for the AGEDD Adult Pneumococcal Burden Study Team (2013) · PLoS ONE · doi:10.1371/journal.pone.0060273 · Cited by 435
Viral Infection in Patients with Severe Pneumonia Requiring Intensive Care Unit Admission
Choi, S.-H., Hong, S.-B., Ko, G.-B., Lee, Y., Park, H. J., Park, S.-Y., Moon, S. M., Cho, O.-H., Park, K.-H., Chong, Y. P., et al. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201112-2240oc · Cited by 353
Balsamo, G., Maxted, A. M., Midla, J. W., Murphy, J. M., Wohrle, R., Edling, T. M., Fish, P. H., Flammer, K., Hyde, D., Kutty, P. K., et al. (2017) · Journal of Avian Medicine and Surgery · doi:10.1647/217-265 · Cited by 272
Diao, Z., Han, D., Zhang, R., & Li, J. (2022) · Journal of Advanced Research · doi:10.1016/j.jare.2021.09.012 · Cited by 265
Procalcitonin as a Marker of Etiology in Adults Hospitalized With Community-Acquired Pneumonia
Self, W. H., Balk, R. A., Grijalva, C. G., Williams, D. J., Zhu, Y., Anderson, E. J., Waterer, G. W., Courtney, D. M., Bramley, A. M., Trabue, C., et al. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix317 · Cited by 257
Self-citationThe impact of bacterial and viral co‐infection in severe influenza
Blyth, C. C., Webb, S. A. R., Kok, J., Dwyer, D. E., van Hal, S. J., Foo, H., Ginn, A. N., Kesson, A. M., Seppelt, I., Iredell, J. R., et al. (2013) · Influenza and Other Respiratory Viruses · doi:10.1111/j.1750-2659.2012.00360.x · Cited by 117
(2010) · PubMed · Cited by 36
Bjarnason, A., Thorleifsdottir, G., Löve, A., Gudnason, J. F., Asgeirsson, H., Hallgrimsson, K. L., Kristjansdottir, B. S., Haraldsson, G., Baldursson, O., Kristinsson, K. G., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046816 · Cited by 30
(2010) · PubMed · Cited by 27
Metadata
- Authors
- Charles, P. G. P., Whitby, M., Fuller, A. J., Stirling, R., Wright, A. A., Korman, T. M., Holmes, P. W., Christiansen, K. J., Waterer, G. W., Pierce, R. J. P., Mayall, B. C., Armstrong, J. G., Catton, M. G., Nimmo, G. R., Johnson, B., Hooy, M., Grayson, M. L., & the Australian CAP Study Collaboration
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-05-15
- Volume
- 46
- Issue
- 10
- Pages
- 1513-1521
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2112555704
- Cited by
- 225
- References
- 0
- FWCI
- 12.26
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.